VRCA - Verrica Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $17. This is a potential upside of $245.13 (271.18%) from yesterday's end of day stock price of $4.58.

Verrica Pharmaceuticals's activity chart (see below) currently has 16 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.76% with an average time for these price targets to be met of 163.36 days.

Highest price target for VRCA is $17, Lowest price target is $17, average price target is $17.

Most recent stock forecast was given by KEMP DOLLIVER from BROOKLINE on 18-Dec-2025. First documented stock forecast 10-Jul-2018.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Dec-2025

$17

$12.62 (288.13%)

8 months 28 days ago
(18-Dec-2025)

0/2 (0%)

$8.89 (109.62%)

Buy Since 21-Oct-2024

$20

$13.16 (192.40%)

$10

1 years 1 months 2 days ago
(13-Aug-2025)

1/2 (50%)

$13.41 (203.49%)

15

Hold Since 05-Nov-2024

1 years 4 months 1 days ago
(14-May-2025)

3/3 (100%)

$-66.3 (-78.65%)

657

Hold Since 08-Apr-2025

1 years 5 months 7 days ago
(08-Apr-2025)

2/6 (33.33%)

$-80.9 (-85.25%)

602

Buy Since 22-Mar-2023

$3

$-3.84 (-56.14%)

$12

1 years 8 months 9 days ago
(06-Jan-2025)

1/3 (33.33%)

$-3.74 (-55.49%)

141

Show more analysts

Please expand the browser size to see the chart

What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?

On average it took 163 days for the stock forecasts to be reached, with an average price target met ratio of 29.76%.

Which analyst most recently updated their price target on VRCA (Verrica Pharmaceuticals)?

Kemp Dolliver

Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?

Kemp Dolliver works at BROOKLINE and has 3 price targets and 2 ratings on VRCA

Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?

Ken Cacciatore with the highest potential upside of $2495.62

Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?

Glen Santangelo with the lowest potential downside of -$3.84

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?